All Stories

  1. Cancer suppresses mitochondrial chaperone activity in macrophages to drive immune evasion
  2. Engineering TME-gated inducible CAR-T cell therapy for solid tumors
  3. Piezo1deletion enhances cross-priming of CD8+ T cells by tumor-infiltrating CD11b+ dendritic cells
  4. Piezo1 restrains proinflammatory response but is essential in T-cell–mediated immunopathology
  5. Oral transforming growth factor‐beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti‐tumor immunity
  6. Targeting the chromatin binding of exportin-1 disrupts NFAT and T cell activation
  7. Neutrophil extracellular traps induced by chemotherapy inhibit tumor growth in murine models of colorectal cancer
  8. Piezo1 facilitates optimal T cell activation during tumor challenge
  9. Cryoablation-induced immune response is dependent on functional STING signaling in cancer cells
  10. Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
  11. Data from p35 is a Crucial Player in NK-cell Cytotoxicity and TGFβ-mediated NK-cell Dysfunction
  12. Data from p35 is a Crucial Player in NK-cell Cytotoxicity and TGFβ-mediated NK-cell Dysfunction
  13. FIGURE 2 from p35 is a Crucial Player in NK-cell Cytotoxicity and TGFβ-mediated NK-cell Dysfunction
  14. FIGURE 2 from p35 is a Crucial Player in NK-cell Cytotoxicity and TGFβ-mediated NK-cell Dysfunction
  15. FIGURE 3 from p35 is a Crucial Player in NK-cell Cytotoxicity and TGFβ-mediated NK-cell Dysfunction
  16. FIGURE 3 from p35 is a Crucial Player in NK-cell Cytotoxicity and TGFβ-mediated NK-cell Dysfunction
  17. FIGURE 4 from p35 is a Crucial Player in NK-cell Cytotoxicity and TGFβ-mediated NK-cell Dysfunction
  18. FIGURE 4 from p35 is a Crucial Player in NK-cell Cytotoxicity and TGFβ-mediated NK-cell Dysfunction
  19. FIGURE 5 from p35 is a Crucial Player in NK-cell Cytotoxicity and TGFβ-mediated NK-cell Dysfunction
  20. FIGURE 5 from p35 is a Crucial Player in NK-cell Cytotoxicity and TGFβ-mediated NK-cell Dysfunction
  21. FIGURE 6 from p35 is a Crucial Player in NK-cell Cytotoxicity and TGFβ-mediated NK-cell Dysfunction
  22. FIGURE 6 from p35 is a Crucial Player in NK-cell Cytotoxicity and TGFβ-mediated NK-cell Dysfunction
  23. p35 is a Crucial Player in NK-cell Cytotoxicity and TGFβ-mediated NK-cell Dysfunction
  24. PIEZO1Deletion in CD11b+ Cells Suppresses Rhabdomyosarcoma Tumor Rejection and Generates a Tumor-Permissive Immune Landscape
  25. Oral TGF-βR1 inhibitor Vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti-tumor immunity
  26. Ectopic Tumor VCAM-1 Expression in Cancer Metastasis and Therapy Resistance
  27. Overexpression of VEGF in the MOPC 315 Plasmacytoma Induces Tumor Immunity in Mice
  28. Detailing the mechanism of CDK5-mediated PD-L1 regulation in Medulloblastoma
  29. Winnie-APCMin/+ Mice: A Spontaneous Model of Colitis-Associated Colorectal Cancer Combining Genetics and Inflammation
  30. Intravenous immunoglobulin therapy enhances suppressive regulatory T cells and decreases innate lymphoid cells in children with immune thrombocytopenia
  31. Chemical disruption of the pyroptotic pore-forming protein gasdermin D inhibits inflammatory cell death and sepsis
  32. Biomimetic post-capillary venule expansions for leukocyte adhesion studies
  33. Optimizing Tumor Microenvironment for Cancer Immunotherapy: β-Glucan-Based Nanoparticles
  34. Multifactorial regulators of tumor programmed death-ligand 1 (PD-L1) response
  35. CCL3 augments tumor rejection and enhances CD8+ T cell infiltration through NK and CD103+ dendritic cell recruitment via IFNγ
  36. Systemic administration of β-glucan of 200 kDa modulates melanoma microenvironment and suppresses metastatic cancer
  37. CCL3 Enhances Antitumor Immune Priming in the Lymph Node via IFNγ with Dependency on Natural Killer Cells
  38. Live-cell visualization of gasdermin D-driven pyroptotic cell death
  39. Notch2 blockade enhances hematopoietic stem cell mobilization and homing
  40. Nanoparticle Systems Modulating Myeloid-Derived Suppressor Cells for Cancer Immunotherapy
  41. Fibroblastic niches prime T cell alloimmunity through Delta-like Notch ligands
  42. Adoptive natural killer cell therapy is effective in reducing pulmonary metastasis of Ewing sarcoma
  43. Plant viral nanoparticles-based HER2 vaccine: Immune response influenced by differential transport, localization and cellular interactions of particulate carriers
  44. Cyclin-dependent kinase 5 activity is required for allogeneic T-cell responses after hematopoietic cell transplantation in mice
  45. Abstract A050: Cdk5 disruption attenuates tumor PD-L1 expression via regulation of IFN-γ signaling components and promotes antitumor immunity
  46. Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity
  47. Transforming growth factor-β1 sustains the survival of Foxp3+ regulatory cells during late phase of oropharyngeal candidiasis infection
  48. Unique Transcompartmental Bridge: Antigen-Presenting Cells Sampling across Endothelial and Mucosal Barriers
  49. Transient Surface CCR5 Expression by Naive CD8+ T Cells within Inflamed Lymph Nodes Is Dependent on High Endothelial Venule Interaction and Augments Th Cell–Dependent Memory Response
  50. Multiple Administrations of Viral Nanoparticles Alter in Vivo Behavior—Insights from Intravital Microscopy
  51. Aberrant Notch Signaling in the Bone Marrow Microenvironment of Acute Lymphoid Leukemia Suppresses Osteoblast-Mediated Support of Hematopoietic Niche Function
  52. Abstract IA28: Immunological insights from tracking dynamic cellular behavior in lymph nodes and tissues
  53. Abstract B158: Cyclin dependent kinase-5 regulates IFNγ induced PD-L1 expression via IRF-1 in medulloblastoma
  54. Cx25 contributes to leukemia cell communication and chemosensitivity
  55. Polyphenol administration impairs T-cell proliferation by imprinting a distinct dendritic cell maturational profile
  56. Dysregulated Intrahepatic CD4+ T-Cell Activation Drives Liver Inflammation in Ileitis-Prone SAMP1/YitFc Mice
  57. Notch Receptor-Ligand Engagement Maintains Hematopoietic Stem Cell Quiescence and Niche Retention
  58. Focal transient CNS vessel leak provides a tissue niche for sequential immune cell accumulation during the asymptomatic phase of EAE induction
  59. Triterpenoid inducers of Nrf2 signaling as potential therapeutic agents in sickle cell disease: a review
  60. Intravital Imaging of Axonal Interactions with Microglia and Macrophages in a Mouse Dorsal Column Crush Injury
  61. The roles of blood-derived macrophages and resident microglia in the neuroinflammatory response to implanted Intracortical microelectrodes
  62. Comparison of intravital thinned skull and cranial window approaches to study CNS immunobiology in the mouse cortex
  63. High-resolution intravital imaging reveals that blood-derived macrophages but not resident microglia facilitate secondary axonal dieback in traumatic spinal cord injury
  64. Administration of Reconstituted Polyphenol Oil Bodies Efficiently Suppresses Dendritic Cell Inflammatory Pathways and Acute Intestinal Inflammation
  65. The prevalence of hypertension and abnormal kidney function in children with sickle cell disease –a cross sectional review
  66. Chemokines as Cancer Vaccine Adjuvants
  67. Extravascular CX3CR1+Cells Extend Intravascular Dendritic Processes into Intact Central Nervous System Vessel Lumen
  68. Dynamic Imaging of Marrow-Resident Granulocytes Interacting with Human Mesenchymal Stem Cells upon Systemic Lipopolysaccharide Challenge
  69. Viewing Transplantation Immunology Through Today's Lens: New Models, New Imaging, and New Insights
  70. Quantification of lymph node transit times reveals differences in antigen surveillance strategies of naïve CD4 + and CD8 + T cells
  71. Cutaneous penetration of the topically applied photosensitizer Pc 4 as detected by intravital 2-photon laser scanning microscopy
  72. Intravital Imaging of the Mouse Popliteal Lymph Node
  73. Direct In Vivo Evidence for Tumor Propagation by Glioblastoma Cancer Stem Cells
  74. Establishing a Novel In Vivo Platform to Interrogate the Effects of Pharmacologic and Molecularly Targeted Modulation of CDK5 in the Invasive and Metastatic Potential of Medulloblastoma in Live Experimental Animals
  75. Direct Visualization of Tumor Propagation by Cancer Stem Cells and Associated Tissue Responses
  76. A Novel Role for Lymphocyte Expression of the Cyclin-Dependent Kinase 5 (CDK5) in the Generation of Allogeneic T Cell Responses After BMT
  77. Cyclin-dependent kinase 5 activity is required for T cell activation and induction of experimental autoimmune encephalomyelitis
  78. Cyclin-dependent kinase 5 activity is required for T cell activation and induction of experimental autoimmune encephalomyelitis
  79. Mycobacterium tuberculosis and TLR2 Agonists Inhibit Induction of Type I IFN and Class I MHC Antigen Cross Processing by TLR9
  80. Fucose-deficient hematopoietic stem cells have decreased self-renewal and aberrant marrow niche occupancy
  81. Bulging glands? Blame it on B cells
  82. Visualizing Immune Surveillance in Tumor Microenvironment with Two-photon Microscopy
  83. Comparative ultrastructural study of human corpus cavernosum during ageing
  84. Making friends in out-of-the-way places: how cells of the immune system get together and how they conduct their business as revealed by intravital imaging
  85. Highways, byways and breadcrumbs: directing lymphocyte traffic in the lymph node
  86. L-selectin-negative CCR7− effector and memory CD8+ T cells enter reactive lymph nodes and kill dendritic cells
  87. Watching Immune Cells in Action
  88. Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement
  89. Extrafollicular Activation of Lymph Node B Cells by Antigen-Bearing Dendritic Cells
  90. Intravital 2-Photon Microscopy of Dendritic Cell Extension Sampling Pathogen Bacteria Into the Small Bowel Lumen
  91. Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell–dendritic cell interaction
  92. Natural killer cell behavior in lymph nodes revealed by static and real-time imaging
  93. An extended vision for dynamic high-resolution intravital immune imaging
  94. Illuminating the Landscape of In Vivo Immunity
  95. Antigen-specific cancer immunotherapy using a GM-CSF secreting allogeneic tumor cell-based vaccine
  96. The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product.
  97. Enhanced Immune Priming with Spatial Distribution of Paracrine Cytokine Vaccines
  98. In Vivo Cross-Priming of MHC Class I–Restricted Antigens Requires the TAP Transporter
  99. Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo?
  100. A reassessment of the role of B7-1 expression in tumor rejection.
  101. Localization of epstein-barr virus-encoded small RNA-1 by in situ reverse transcription: Demonstration of cDNA generation in formalin-fixed paraffin-embedded tissue sections
  102. Simplified High-Sensitivity Sequencing of a Major Histocompatibility Complex Class I-Associated Immunoreactive Peptide Using Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry
  103. Photodehalogenation of 4-haloindoles